1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 2:Imaging and clinical results
Patient (no.) mg rt-PA Order Antiplatelet Hematoma Sites of Infarction Time (h) Window of Stroke Time (h) Window of Coma NIHSS, Prior GCS, Prior MRS, After 3 Months 1 80 after Tirofiban ICH, SAH c 7 5 21 6 6 2 — — — o 5 4.5 26 4 3 3 40 before — — c, o 18 3 25 5 6 4 * — ICH c 216 6 25 5 6 5 — — — — 8.5 8 23 5 1 6 *120 — ICH, SAH b, c 4 0 19 10 6 7 — Tirofiban — c 7.5 0 20 13 1 8 — Tirofiban — b 7 4 21 7 5 9 15 before — — — 0 0 n.a.** n.a.** 0 10 — Tirofiban SAH b 84 0 12 13 3 11 — Tirofiban — c 12 6 13 4 6 12 60 after — SAH c, o 15 0 14 13 1
* Note.—: no access-no angiojet treatment possible;
** Note.—: patient was under general anesthesia, when occlusion occurred; b = brainstem infarction; c = cerebellar infarction; GCS: Glasgow coma scale; ICH: intracerebral hemorrhage; MRS: Modified Rankin Scale (0 = normal, 6 = deceased); n.a.: not applicable; NIH: National Institutes of Health Stroke Scale; o = occipital and thalamic infarction; SAH: subarachnoid hemorrhage.